Dan Spiegelman

机构：Montreal Neurological Institute and Hospital, Washington University in St. Louis, McGill University · ORCID：0000-0001-6450-3238

发表论文 37 篇 · 总被引 220 次 · h-index 8

代表论文

• GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease (2022 · Brain · 被引 39)
• Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study (2022 · BMC Medicine · 被引 24)
• Association of Rare Variants in ARSA with Parkinson's Disease (2023 · Movement Disorders · 被引 14)
• Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study (2024 · Journal of Clinical Investigation · 被引 10)
• Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist (2023 · Cancer Immunology Immunotherapy · 被引 9)
• Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study (2024 · Journal of Clinical Investigation · 被引 8)